Long-term methadone treatment reduces phosphorylation of CaMKII in rat brain

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 6, 2012, Pages 843-847

  Andersen, Jannike M ^a   Klykken, Christine ^a   Mørland, Jørg ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

cognitive functioning; methadone; rat

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; METHADONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; LEARNING; MALE; MEMORY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HIPPOCAMPUS; LEARNING; MALE; MEMORY; METHADONE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MORPHINE; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 84861100255     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01469.x     Document Type: Article

References (24)

1. Oliver P, et al,. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service. Addiction 2010; 105: 732-739.
2. Darke S, et al,. Cognitive impairment among methadone maintenance patients. Addiction 2000; 95: 687-695. (Pubitemid 30324248)
3. Mintzer MZ, et al,. Opioid abuse and cognitive performance. Drug Alcohol Depend 2005; 78: 225-230. (Pubitemid 40544611)
4. Verdejo A, et al,. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005; 78: 283-288. (Pubitemid 40694050)
5. Prosser J, et al,. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006; 84: 240-247. (Pubitemid 44308379)
6. Prosser J, et al,. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend 2009; 104: 228-240.
7. Andersen JM, et al,. Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue. Pharmacol Biochem Behav 2011; 98: 412-416.
8. Myhrer T,. Exploratory behavior and reaction to novelty in rats with hippocampal perforant path systems disrupted. Behav Neurosci 1988; 102: 356-362.
9. Fukunaga K, Miyamoto E,. A working model of CaM kinase II activity in hippocampal long-term potentiation and memory. Neurosci Res 2000; 38: 3-17.
10. Lowry OH, et al,. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
11. Dalley JW, et al,. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004; 28: 771-784. (Pubitemid 39535871)
12. 2+/calmodulin-dependent protein kinase in rat brain. J Neurosci 1985; 5: 3270-3277. (Pubitemid 16182607)
13. Tan SE, Liang KC,. Spatial learning alters hippocampal calcium/calmodulin-dependent protein kinase II activity in rats. Brain Res 1996; 711: 234-240.
14. 2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 2005; 28: 1342-1354. (Pubitemid 41379679)
15. Cooke SF, Bliss TV,. Plasticity in the human central nervous system. Brain 2006; 129: 1659-1673. (Pubitemid 43999401)
16. Spain JW, Newsom GC,. Chronic opioids impair acquisition of both radial maze and Y-maze choice escape. Psychopharmacology 1991; 105: 101-106.
17. Li Z, et al,. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system. Pharmacol Biochem Behav 2001; 68: 507-513.
18. Zhong W, et al,. Opiate withdrawal induces dynamic expressions of AMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. Life Sci 2006; 79: 861-869.
19. Wang Z, et al,. On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats. Mol Pain 2011; 7: 68.
20. Mestek A, et al,. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 1995; 15: 2396-2406.
21. Leander JD, McCleary PE,. Opioid and nonopioid behavioral effects of methadone isomers. J Pharmacol Exp Ther 1982; 220: 592-596. (Pubitemid 12152173)
22. Davis AM, Inturrisi CE,. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther 1999; 289: 1048-1053. (Pubitemid 29191265)
23. Joseph H, et al,. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med 2000; 67: 347-364.
24. Wolff K, et al,. The pharmacokinetics of methadone in healthy subjects and opiate users. Br J Clin Pharmacol 1997; 44: 325-334. (Pubitemid 27402106)